HIV-Risk Behavior Among Adults with Opioid Use Disorder During 12 Months Following Pre-trial Detention: Results from a Randomized Trial of Methadone Treatment

Overview

Journal AIDS Behav

Specialty Infectious Diseases

Date 2020 Nov 16

PMID 33196937

Citations 1

Authors

M M Mitchell

S M Kelly

K E OGrady

J H Jaffe

S G Mitchell

R P Schwartz

Affiliations

Soon will be listed here.

Abstract

This was a three group randomized clinical trial of interim methadone and patient navigation involving 225 pre-trial detainees with opioid use disorder in Baltimore. The HIV Risk Assessment Battery (RAB) was administered at baseline (in jail), and at 6 and 12 months post-release. Generalized linear mixed model analyses indicated the condition × time interaction effect failed to reach significance (ps > .05) for both the drug risk and sex risk subscale scores. Therefore, findings suggest that there were no intervention effects on drug or sex risk behaviors. However, increased use of cocaine at baseline was associated with increases in drug- (b = .04, SE = .02) and sex-risk (b = .01, SE = .003) behaviors. These results suggest that interventions targeting cocaine use among pre-trial detainees may serve as a means of reducing HIV risk associated with drug- and sex-risk behaviors.Clinical Trials Registration: Clinicaltrials.gov NCT02334215.

Citing Articles

Opioid-specific medication-assisted therapy and its impact on criminal justice and overdose outcomes.

Strange C, Manchak S, Hyatt J, Petrich D, Desai A, Haberman C Campbell Syst Rev. 2023; 18(1):e1215.

PMID: 36913194 PMC: 8742132. DOI: 10.1002/cl2.1215.

References

Dolan K, Wodak A . HIV transmission in a prison system in an Australian State. Med J Aust. 1999; 171(1):14-7. DOI: 10.5694/j.1326-5377.1999.tb123490.x. View

Harris N, Satcher Johnson A, Huang Y, Kern D, Fulton P, Smith D . Vital Signs: Status of Human Immunodeficiency Virus Testing, Viral Suppression, and HIV Preexposure Prophylaxis - United States, 2013-2018. MMWR Morb Mortal Wkly Rep. 2019; 68(48):1117-1123. PMC: 6897528. DOI: 10.15585/mmwr.mm6848e1. View

Rudd R, Aleshire N, Zibbell J, Gladden R . Increases in Drug and Opioid Overdose Deaths--United States, 2000-2014. MMWR Morb Mortal Wkly Rep. 2016; 64(50-51):1378-82. DOI: 10.15585/mmwr.mm6450a3. View

Mitchell M, Gryczynski J, Mitchell S, Kelly S, OGrady K, Monico L . A Latent Class Analysis of HIV Risk Factors Among Men and Women with Opioid Use Disorder in Pre-trial Detention. AIDS Behav. 2019; 24(6):1776-1783. DOI: 10.1007/s10461-019-02726-y. View

Rao A, Tobin K, Davey-Rothwell M, Latkin C . Social Desirability Bias and Prevalence of Sexual HIV Risk Behaviors Among People Who Use Drugs in Baltimore, Maryland: Implications for Identifying Individuals Prone to Underreporting Sexual Risk Behaviors. AIDS Behav. 2017; 21(7):2207-2214. PMC: 5521816. DOI: 10.1007/s10461-017-1792-8. View

Latkin C, Vlahov D, Anthony J . Socially desirable responding and self-reported HIV infection risk behaviors among intravenous drug users. Addiction. 1993; 88(4):517-26. DOI: 10.1111/j.1360-0443.1993.tb02058.x. View

Wilson M, Kinlock T, Gordon M, OGrady K, Schwartz R . Postprison release HIV-risk behaviors in a randomized trial of methadone treatment for prisoners. Am J Addict. 2012; 21(5):476-87. PMC: 3422766. DOI: 10.1111/j.1521-0391.2012.00250.x. View

Mattick R, Breen C, Kimber J, Davoli M . Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev. 2014; (2):CD002207. PMC: 10617756. DOI: 10.1002/14651858.CD002207.pub4. View

McKenzie M, Zaller N, Dickman S, Green T, Parihk A, Friedmann P . A randomized trial of methadone initiation prior to release from incarceration. Subst Abus. 2012; 33(1):19-29. PMC: 3278074. DOI: 10.1080/08897077.2011.609446. View

10.

Sharma A, OGrady K, Kelly S, Gryczynski J, Mitchell S, Schwartz R . Pharmacotherapy for opioid dependence in jails and prisons: research review update and future directions. Subst Abuse Rehabil. 2016; 7:27-40. PMC: 4853155. DOI: 10.2147/SAR.S81602. View

11.

Dolan K, Wodak A, Hall W . Methadone maintenance treatment reduces heroin injection in New South Wales prisons. Drug Alcohol Rev. 2005; 17(2):153-8. DOI: 10.1080/09595239800186951. View

12.

Milloy M, Buxton J, Wood E, Li K, Montaner J, Kerr T . Elevated HIV risk behaviour among recently incarcerated injection drug users in a Canadian setting: a longitudinal analysis. BMC Public Health. 2009; 9:156. PMC: 2695456. DOI: 10.1186/1471-2458-9-156. View

13.

Culbert G, Waluyo A, Iriyanti M, Muchransyah A, Kamarulzaman A, Altice F . Within-prison drug injection among HIV-infected male prisoners in Indonesia: a highly constrained choice. Drug Alcohol Depend. 2015; 149:71-9. PMC: 5108518. DOI: 10.1016/j.drugalcdep.2015.01.018. View

14.

Lott D, Strain E, Brooner R, Bigelow G, Johnson R . HIV risk behaviors during pharmacologic treatment for opioid dependence: a comparison of levomethadyl acetate [corrected] buprenorphine, and methadone. J Subst Abuse Treat. 2006; 31(2):187-94. DOI: 10.1016/j.jsat.2006.04.005. View

15.

Bruce R . Methadone as HIV prevention: high volume methadone sites to decrease HIV incidence rates in resource limited settings. Int J Drug Policy. 2009; 21(2):122-4. PMC: 2839048. DOI: 10.1016/j.drugpo.2009.10.004. View

16.

Kelly S, OGrady K, Jaffe J, Gandhi D, Schwartz R . Improvements in outcomes in methadone patients on probation/parole regardless of counseling early in treatment. J Addict Med. 2013; 7(2):133-8. PMC: 3618548. DOI: 10.1097/ADM.0b013e318284a0c1. View

17.

Schwartz R, Highfield D, Jaffe J, Brady J, Butler C, Rouse C . A randomized controlled trial of interim methadone maintenance. Arch Gen Psychiatry. 2006; 63(1):102-9. DOI: 10.1001/archpsyc.63.1.102. View

18.

Bux D, Lamb R, Iguchi M . Cocaine use and HIV risk behavior in methadone maintenance patients. Drug Alcohol Depend. 1995; 37(1):29-35. DOI: 10.1016/0376-8716(94)01058-s. View

19.

Baughman M, Tossone K, Singer M, Flannery D . Evaluation of Treatment and Other Factors That Lead to Drug Court Success, Substance Use Reduction, and Mental Health Symptomatology Reduction Over Time. Int J Offender Ther Comp Criminol. 2018; 63(2):257-275. DOI: 10.1177/0306624X18789832. View

20.

Karki P, Shrestha R, Huedo-Medina T, Copenhaver M . The Impact of Methadone Maintenance Treatment on HIV Risk Behaviors among High-Risk Injection Drug Users: A Systematic Review. Evid Based Med Public Health. 2016; 2. PMC: 4824190. View